title: Mantle cell lymphoma successfully treated in a patient with multiple endocrine neoplasia type 2: a rare combination of two malignancies.
authors.forename: Maciej
authors.initials: M
authors.lastname: Machaczka
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols; D018276:Carcinoma, Medullary / Q000150:complications / Q000473:pathology; D003520:Cyclophosphamide; D004317:Doxorubicin; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000150:complications* / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D018813:Multiple Endocrine Neoplasia Type 2a / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D009378:Neoplasms, Multiple Primary / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D011241:Prednisone; D000069283:Rituximab; D033581:Stem Cell Transplantation; D013964:Thyroid Neoplasms / Q000150:complications / Q000473:pathology; D014750:Vincristine
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone